Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03355560 · ClinicalTrials.gov registry record · Phase 2

Adjuvant Nivolumab After Salvage Resection in Head and Neck Cancer Patients Previously Treated With Definitive Therapy

A Phase 2 study of Head and Neck Cancer, sponsored by Trisha Wise-Draper.

Active
Registry status
Phase 2
Development phase
39
Enrollment target
2
Study locations

NCT03355560 is a Phase 2 study of Head and Neck Cancer that is active but no longer recruiting, run by Trisha Wise-Draper. The registered enrollment target is 39 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (85% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03355560, a Phase 2 study of Head and Neck Cancer, is active but no longer recruiting, sponsored by Trisha Wise-Draper.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
39 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this research study is to test the safety and efficacy of nivolumab after salvage resection in head and neck cancer in patients that have previously received definitive radiation with or without chemotherapy.

Conditions Studied

Head and Neck Cancer

Interventions

  • DRUG Nivolumab

Study Locations (2)

Michigan

  • Karmanos Cancer Institute - Detroit

Ohio

  • UC Health - Cincinnati

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2017-12-06
Est. Completion 2024-07
Phase Phase 2

Sponsor

Trisha Wise-Draper

6 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03355560

The ClinicalTrials.gov registry entry for NCT03355560 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (85% lower). The listed sponsor is Trisha Wise-Draper, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 1 intervention - of which Nivolumab is the first listed.

NCT03355560 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Michigan, Ohio.

Frequently Asked Questions

What is clinical trial NCT03355560 about?

NCT03355560 is a clinical study titled "Adjuvant Nivolumab After Salvage Resection in Head and Neck Cancer Patients Previously Treated With Definitive Therapy". The purpose of this research study is to test the safety and efficacy of nivolumab after salvage resection in head and neck cancer in patients that have previously received definitive radiation with or without chemotherapy.

What is the current status of trial NCT03355560?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 39 participants. The study started on 2017-12-06. Estimated completion is 2024-07.

What conditions does trial NCT03355560 study?

This clinical trial studies the following conditions: Head and Neck Cancer.

What interventions are being tested in trial NCT03355560?

The interventions under investigation include: Nivolumab (DRUG).

Who is sponsoring clinical trial NCT03355560?

This trial is sponsored by Trisha Wise-Draper, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03355560 being conducted?

This trial has 2 study locations across Michigan, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Head and Neck Cancer

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.